Investor Notice: Robbins LLP Informs Investors of the Regencell Bioscience Holdings Limited Class Action
Regencell Bioscience Holdings Limited - Ordinary Shares (RGC)
Last regencell bioscience holdings limited - ordinary shares earnings: 10/24 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
investor.regmovies.com
Company Research
Source: Business Wire
SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Regencell Bioscience Holdings Limited (NASDAQ: RGC) securities between October 28, 2024 and October 31, 2025. Regencell is a purported early-stage bioscience company focused on the research, development, and commercialization of traditional Chinese medicine (“TCM”) for the treatment of attention-deficit/hyperactivity disorder (“ADHD”) and autism spectrum disorder (“ASD”).For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Robbins LLP is Investigating Allegations that Regencell Bioscience Holdings Limited (RGC) was Impacted by a Stock Manipulation SchemeAccording to the complaint, during the class period, defendants made false and/or misleading statements and/or failed to disclose that: (i) Regencell was vulnerable and/or subject to market manipulation; (ii) th
Show less
Read more
Impact Snapshot
Event Time:
RGC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGC alerts
High impacting Regencell Bioscience Holdings Limited - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
RGC
News
- Securities Fraud Investigation Into Regencell Bioscience Holdings Limited (RGC) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. CruzBusiness Wire
- ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Regencell Bioscience Holdings Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action - RGCACCESS Newswire
- RGC LAWSUIT ALERT: Levi & Korsinsky Notifies Regencell Bioscience Holdings Limited Investors of a Class Action Lawsuit and Upcoming DeadlinePR Newswire
- Pomerantz LLP Announces The Filing of a Class Action Lawsuit Against Regencell Bioscience Holdings Limited – RGCACCESS Newswire
- RGC INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regencell Bioscience Holdings Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!ACCESS Newswire
RGC
Sec Filings
- 4/17/26 - Form 6-K
- 3/30/26 - Form 6-K
- 3/30/26 - Form 6-K
- RGC's page on the SEC website